spiroxatrine has been researched along with urapidil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beller, KD; Kolassa, N; Sanders, KH | 1 |
| Beller, KD; Bischler, P; Kolassa, N; Sanders, KH | 1 |
1 review(s) available for spiroxatrine and urapidil
| Article | Year |
|---|---|
Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Brain Stem; Cats; Dioxanes; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Heart Rate; Infusions, Intravenous; Male; Piperazines; Receptors, Serotonin; Spiro Compounds; Tetrahydronaphthalenes | 1989 |
1 other study(ies) available for spiroxatrine and urapidil
| Article | Year |
|---|---|
Interaction of urapidil with brain serotonin-1A receptors increases the blood pressure reduction due to peripheral alpha-adrenoceptor inhibition.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Cats; Dioxanes; Female; Male; Piperazines; Receptors, Serotonin; Serotonin Antagonists; Spiro Compounds; Tetrahydronaphthalenes | 1988 |